Commonly replaced joints include the hip, knee, and shoulder. Partial joint replacements are also performed for specific cases.

The target INR range for patients on warfarin therapy varies depending on their condition but is typically between 2.0 and 3.0.

Frequency of testing depends on individual patient needs, but initially, it may be done weekly or bi-weekly until stable, then less frequently thereafter.

Yes, the PT / INR Test can help diagnose various clotting disorders, including those related to liver disease or genetic clotting factor deficiencies.

Medications, dietary changes, liver function, and underlying health conditions can all influence PT / INR results.

Yes, the PT / INR Test is a safe and standard diagnostic procedure used worldwide to monitor blood clotting ability and adjust anticoagulant therapy.

HIV (Human Immunodeficiency Virus) is a virus that attacks the body’s immune system, specifically the CD4 cells (T cells), which help the immune system fight infections.

Anyone at risk of HIV exposure or needing routine screening should undergo this test. This includes sexually active individuals with multiple partners, intravenous drug users, and individuals with potential exposure through blood transfusions or needle-sharing.

Yes, the HIV Spot Test is highly accurate in detecting HIV antibodies. However, a positive result requires confirmation through additional tests.

No, additional tests are needed to differentiate between HIV-1 and HIV-2, which are two different strains of the virus.

A positive result indicates possible HIV infection. Further confirmatory tests and counseling will be provided to determine the next steps for treatment and care.